Stratos Wealth Partners, LTD. - SPDR SER TR ownership

SPDR SER TR's ticker is HYMB and the CUSIP is 78464A284. A total of 232 filers reported holding SPDR SER TR in Q3 2022. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$1,053,797
-20.5%
44,240
-16.5%
0.02%
-23.3%
Q2 2023$1,324,951
-1.9%
52,976
-1.8%
0.03%
-16.7%
Q1 2023$1,351,080
+1.5%
53,956
+98.5%
0.04%
+5.9%
Q4 2022$1,331,417
-94.7%
27,188
-94.8%
0.03%
-95.2%
Q3 2022$25,276,000
+1034.5%
527,462
+1322.6%
0.71%
+1340.8%
Q4 2021$2,228,000
+1144.7%
37,078
+1068.2%
0.05%
+512.5%
Q3 2018$179,000
-13.9%
3,174
-15.0%
0.01%
-11.1%
Q1 2018$208,000
-19.1%
3,736
-19.1%
0.01%
-25.0%
Q4 2017$257,000
-15.5%
4,618
-13.2%
0.01%
-14.3%
Q3 2017$304,000
-16.9%
5,318
-17.3%
0.01%
-26.3%
Q2 2017$366,000
+0.8%
6,433
+0.2%
0.02%
-9.5%
Q1 2017$363,000
-18.2%
6,417
-19.1%
0.02%
-25.0%
Q4 2016$444,000
-60.8%
7,933
-58.5%
0.03%
-63.2%
Q3 2016$1,134,000
-28.9%
19,107
-28.3%
0.08%
-35.6%
Q2 2016$1,594,000
-1.9%
26,655
-5.4%
0.12%
-15.1%
Q1 2016$1,625,000
-1.1%
28,173
-2.2%
0.14%
+1.5%
Q4 2015$1,643,000
+2.6%
28,806
+1.8%
0.14%
-31.8%
Q3 2015$1,602,000
-2.9%
28,308
-4.9%
0.20%
-5.2%
Q2 2015$1,650,000
+52.6%
29,770
+58.5%
0.21%
+64.3%
Q1 2015$1,081,000
-40.7%
18,782
-41.5%
0.13%
-69.9%
Q3 2014$1,823,00032,0960.43%
Other shareholders
SPDR SER TR shareholders Q3 2022
NameSharesValueWeighting ↓
Tradewinds Capital Management, LLC 541,457$12,897,5064.42%
Revolve Wealth Partners, LLC 724,261$17,251,8923.97%
Collaborative Wealth Managment Inc. 246,102$5,862,1513.50%
Erickson Financial Group, LLC 156,095$3,718,1833.48%
Private Ocean, LLC 1,114,426$26,545,6263.37%
Avantax Planning Partners, Inc. 3,021,719$71,977,3473.01%
Orcam Financial Group 90,974$2,166,9902.92%
Running Point Capital Advisors, LLC 158,704$3,780,3292.19%
QP WEALTH MANAGEMENT, LLC 45,803$1,091,0271.90%
High Net Worth Advisory Group LLC 190,751$4,543,7141.82%
View complete list of SPDR SER TR shareholders